Management of post cardiac transplantation immunosuppression and COVID-19: A case report

Rivinius, 2020, COVID-19 among heart transplant recipients in Germany: a multicenter survey, Clin Res Cardiol [Internet], 109, 1531, 10.1007/s00392-020-01722-w Fishman, 2020, Infectious disease division, and transplant center, Massachusetts general hospital and Harvard medical school, Boston M. The immunocompromised transplant recipient and SARS-CoV-2 infection, J. Am. Soc. Nephrol., 31, 1147, 10.1681/ASN.2020040416 Ren, 2020, Epidemiologic and clinical characteristics of heart transplant recipients during the 2019 coronavirus outbreak in Wuhan, China: a descriptive survey report, J. Heart Lung Transplant., 39, 412, 10.1016/j.healun.2020.03.008 Ahluwalia, 2020, A proposed strategy for management of immunosuppression in heart transplant patients with COVID-19, Clin. Transplant., 34, 1, 10.1111/ctr.14032 Li, 2018, Effect of interferon alpha and cyclosporine treatment separately and in combination on Middle East Respiratory Syndrome Coronavirus (MERS-CoV) replication in a human in-vitro and ex-vivo culture model, Antivir. Res., 155, 89, 10.1016/j.antiviral.2018.05.007 Akalin, 2020, Covid-19 and kidney transplantation, N. Engl. J. Med., 10.1056/NEJMc2011117 Rammohan, 2020, Post-transplant immunosuppression and COVID-19: from a double whammy to a mixed blessing, World J. Transplant., 10, 267, 10.5500/wjt.v10.i9.267 Cohen 2020, Dexamethasone in Hospitalized patients with covid-19 — preliminary report, N. Engl. J. Med., 1 Agha, 2020, The SCARE 2020 guideline: updating consensus surgical CAse REport (SCARE) guidelines, Int. J. Surg., 84, 226, 10.1016/j.ijsu.2020.10.034